{"categoria": "NULL", "sottotitolo": "uilpa", "testo": "gilead sciences inc nasda$1$2gild today announced that the company\u2019s \r\n      board of directors has declared cash dividend of $063 per share of \r\n      common stock for the second quarter of 2019 the dividend is payable on \r\n      june 27 2019 to stockholders of record at the close of business on \r\n      june 14 2019 future dividends will be subject to board approval\r\n    \r\n    \r\n\r\n      \r\nabout gilead sciences\r\n    \r\n\r\n    \r\n\r\n      gilead sciences inc is research based biopharmaceutical company that \r\n      discovers develops and commercializes innovative medicines in areas of \r\n      unmet medical need the company strives to transform and simplify care \r\n      for people with life threatening illnesses around the world gilead has \r\n      operations in more than 35 countries worldwide with headquarters in \r\n      foster city california\r\n    \r\n    \r\n\r\n      \r\nfor more information on gilead sciences please visit the company\u2019s \r\n      website at wwwgileadcom \r\n      follow gilead on twitter @gileadsciences or call gilead public affairs \r\n      at 1 800 gilead 5 or 1 650 574 3000\r\n    \r\n\r\n    \r\n\r\n    \r\n\r\n  \r\n\r\n\r\n\r\n\r\nview source version on businesswireco$1$2https://wwwbusinesswirecom/news/home/20190502005789/en/\r\n\r\n    \r\n\r\n      \r\ninvestors\r\nrobin washington650 \r\n      522 5688\r\n    \r\n    \r\n\r\n      sung lee650 524 7792\r\n    \r\n  \r\n\r\npermalin$1$2http://wwwbusinesswirecom/news/home/20190502005789/en", "titolo_articolo": "gilead sciences announces second quarter 2019 dividend", "tags": []}